U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07382479) titled 'NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking Surgery' on Jan. 27.
Brief Summary: A prospective, international, multi-center, interventional trial of advanced epithelial ovarian cancer patients offered three cycles of neoadjuvant chemotherapy (NACT) and triaged with KELIM score. Patients with favorable score will undergo interval debulking surgery (IDS) followed by another 3 cycles, while those with unfavorable score will undergo another 3 cycles of NACT followed by delayed interval debulking surgery (DIDS).
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Ovarian Cancer
Neoadj...